[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Erectile Dysfunction Market Size, Trends, Analysis, and Outlook By Type (Drugs, Devices, Others), By Age Group (Below 40 years, 40 to 60 years, Above 60 years), By Cause (Vascular Disorders and Diabetes, Neurological Disorders, Others), By End-User (Hospitals and ASCs, Clinics), by Region, Country, Segment, and Companies, 2024-2030

March 2024 | 190 pages | ID: E69E5746BB96EN
VPAResearch

US$ 3,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Erectile Dysfunction market size is poised to register 8.36% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Erectile Dysfunction market By Type (Drugs, Devices, Others), By Age Group (Below 40 years, 40 to 60 years, Above 60 years), By Cause (Vascular Disorders and Diabetes, Neurological Disorders, Others), By End-User (Hospitals and ASCs, Clinics).

The future of erectile dysfunction (ED) treatment is influenced by advancements in medical technology, pharmacology, and personalized medicine. Key trends include the development of novel therapies that target the underlying causes of ED, such as vascular dysfunction, hormonal imbalances, and neurological disorders, offering more effective and tailored treatment options for patients. Moreover, there is a growing emphasis on the integration of lifestyle interventions, including exercise, diet, and stress management, as adjunctive therapies to improve overall sexual health and function in individuals with ED. Additionally, there is increasing exploration of regenerative medicine approaches, such as stem cell therapy and tissue engineering, aimed at restoring erectile tissue function and enhancing sexual performance in patients with refractory or severe ED. These trends reflect a shift towards a comprehensive and multidisciplinary approach to ED management, addressing both physiological and psychological factors, and aiming to improve quality of life and sexual satisfaction for affected individuals..

Erectile Dysfunction Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Erectile Dysfunction market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Erectile Dysfunction survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Erectile Dysfunction industry.

Key market trends defining the global Erectile Dysfunction demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Erectile Dysfunction Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Erectile Dysfunction industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Erectile Dysfunction companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Erectile Dysfunction industry

Leading Erectile Dysfunction companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Erectile Dysfunction companies.

Erectile Dysfunction Market Study- Strategic Analysis Review

The Erectile Dysfunction market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
  • Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
  • Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
  • Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
  • Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
Erectile Dysfunction Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Erectile Dysfunction industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Erectile Dysfunction Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Erectile Dysfunction Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Erectile Dysfunction market segments. Similarly, Strong end-user demand is encouraging Canadian Erectile Dysfunction companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Erectile Dysfunction market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Erectile Dysfunction Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Erectile Dysfunction industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Erectile Dysfunction market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Erectile Dysfunction Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Erectile Dysfunction in Asia Pacific. In particular, China, India, and South East Asian Erectile Dysfunction markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Erectile Dysfunction Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Erectile Dysfunction Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Erectile Dysfunction market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Erectile Dysfunction.

Erectile Dysfunction Market Company Profiles

The global Erectile Dysfunction market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Adamed Pharma S.A , Auxilium Pharmaceuticals Inc, Bayer AG, Boston Scientific Corp, Coloplast Group, Eli Lilly and Company, Petros Pharmaceuticals Inc, Pfizer Inc, Promedon GmbH, Rigicon Inc, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, VIVUS Inc.

Recent Erectile Dysfunction Market Developments

The global Erectile Dysfunction market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Erectile Dysfunction Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • SWOT Profile
  • Market Dynamics- Trends, Drivers, Challenges
  • Porter’s Five Forces Analysis
  • Macroeconomic Impact Analysis
  • Case Scenarios- Low, Base, High
Market Segmentation:

By Type

Stationary 3D and 4D Ultrasound Devices

Portable 3D and 4D Ultrasound Devices

By Display

Color Ultrasound

B/W Ultrasound

By Portability

Trolley or Cart-Based Ultrasound Systems

Compact/Handheld Ultrasound Systems

Point-of-Pare (PoC) Ultrasound Systems

By Application

Radiology or General Imaging

Obstetrics or Gynecology

Cardiology

Urology

Vascular

Orthopedic and Musculoskeletal

Pain Management

Others

By End-User

Hospitals

Surgical Centers and Diagnostic Centers

Maternity Centers

Ambulatory Care Centers

Research and Academia

Others

Geographical Segmentation:
  • North America (3 markets)
  • Europe (6 markets)
  • Asia Pacific (6 markets)
  • Latin America (3 markets)
  • Middle East Africa (5 markets)
Companies

Adamed Pharma S.A

Auxilium Pharmaceuticals Inc

Bayer AG

Boston Scientific Corp

Coloplast Group

Eli Lilly and Company

Petros Pharmaceuticals Inc

Pfizer Inc

Promedon GmbH

Rigicon Inc

Sun Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd

VIVUS Inc

Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY

1.1 Erectile Dysfunction Market Overview and Key Findings, 2024
1.2 Erectile Dysfunction Market Size and Growth Outlook, 2021- 2030
1.3 Erectile Dysfunction Market Growth Opportunities to 2030
1.4 Key Erectile Dysfunction Market Trends and Challenges
  1.4.1 Erectile Dysfunction Market Drivers and Trends
  1.4.2 Erectile Dysfunction Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Erectile Dysfunction Companies

2. ERECTILE DYSFUNCTION MARKET SIZE OUTLOOK TO 2030

2.1 Erectile Dysfunction Market Size Outlook, USD Million, 2021- 2030
2.2 Erectile Dysfunction Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024

3. ERECTILE DYSFUNCTION MARKET- STRATEGIC ANALYSIS REVIEW

3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis

4. ERECTILE DYSFUNCTION MARKET SEGMENTATION ANALYSIS AND OUTLOOK

4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030

5. REGION-WISE MARKET OUTLOOK TO 2030

5.1 Key Findings for Asia Pacific Erectile Dysfunction Market, 2025
5.2 Asia Pacific Erectile Dysfunction Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Erectile Dysfunction Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Erectile Dysfunction Market, 2025
5.5 Europe Erectile Dysfunction Market Size Outlook by Type, 2021- 2030
5.6 Europe Erectile Dysfunction Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Erectile Dysfunction Market, 2025
5.8 North America Erectile Dysfunction Market Size Outlook by Type, 2021- 2030
5.9 North America Erectile Dysfunction Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Erectile Dysfunction Market, 2025
5.11 South America Pacific Erectile Dysfunction Market Size Outlook by Type, 2021- 2030
5.12 South America Erectile Dysfunction Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Erectile Dysfunction Market, 2025
5.14 Middle East Africa Erectile Dysfunction Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Erectile Dysfunction Market Size Outlook by Application, 2021- 2030

6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030

6.1 US Erectile Dysfunction Market Size Outlook and Revenue Growth Forecasts
6.2 US Erectile Dysfunction Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Erectile Dysfunction Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Erectile Dysfunction Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Erectile Dysfunction Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Erectile Dysfunction Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Erectile Dysfunction Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Erectile Dysfunction Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Erectile Dysfunction Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Erectile Dysfunction Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Erectile Dysfunction Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Erectile Dysfunction Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Erectile Dysfunction Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Erectile Dysfunction Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Erectile Dysfunction Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Erectile Dysfunction Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Erectile Dysfunction Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Erectile Dysfunction Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Erectile Dysfunction Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Erectile Dysfunction Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Erectile Dysfunction Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Erectile Dysfunction Industry Drivers and Opportunities

7. ERECTILE DYSFUNCTION MARKET OUTLOOK ACROSS SCENARIOS

7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case

8. ERECTILE DYSFUNCTION COMPANY PROFILES

8.1 Profiles of Leading Erectile Dysfunction Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Adamed Pharma S.A
Auxilium Pharmaceuticals Inc
Bayer AG
Boston Scientific Corp
Coloplast Group
Eli Lilly and Company
Petros Pharmaceuticals Inc
Pfizer Inc
Promedon GmbH
Rigicon Inc
Sun Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd
VIVUS Inc

9. APPENDIX

9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information


More Publications